Novartis’ £1.79M gene therapy Zolgensma scores cost watchdog’s backing, threatening Biogen’s Spinraza March 8, 2021 Auto Bot News 0 Novartis’ £1.79M gene therapy Zolgensma scores cost watchdog’s backing, threatening Biogen’s Spinraza esagonowsky Mon, 03/08/2021 – 09:16
